Sustainability | June 01, 2023
Glenmark sets GHG emission targets for FY2035
The target boundary includes biogenic land?related emissions and removals from bioenergy feedstock
The target boundary includes biogenic land?related emissions and removals from bioenergy feedstock
Capnopharm’s new CapnoPen is the first PIPAC nebulizer to obtain CE marking under the new MDR regulation 2017/745
Pharmaceutical sales was flat and stood at Rs. 309 crore as compared to Rs. 308 crore in Q4 FY22
Two patents were filed during the quarter ended 31st March, 2023 and the cumulative filings till date are 3239
Product deliveries scheduled in Q3 of 2023
Unani Medicine facilities to be upgraded at Hyderabad, Chennai, Lucknow, Silchar and Bengaluru
The Global Medical Countermeasures Platform will provide equal access safe, high-quality, cost-effective medical countermeasures to the world
This is the second US FDA GMP inspection of this facility within one year
India’s efforts are aimed at boosting health at the last mile
The USFDA had classified Strides Puducherry facility as OAI in May 2019 followed by issuing a warning letter to this site in July 2019.
Subscribe To Our Newsletter & Stay Updated
